| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.11 | 0.08 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.08 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.08 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.08 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.096 | 0.08 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.26 | 0.08 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |